Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

10.0%

2 terminated/withdrawn out of 20 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

14%

2 of 14 completed trials have results

Key Signals

2 recruiting2 with results

Enrollment Performance

Analytics

N/A
18(100.0%)
18Total
N/A(18)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials
NCT06956118Not ApplicableRecruiting

Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Improving Sleep in Visually Impaired Patients

Role: lead

NCT06956105Not ApplicableRecruiting

Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety in Adolescents

Role: lead

NCT05242367Not ApplicableCompleted

Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for PTSD

Role: lead

NCT03640286Not ApplicableCompleted

Vestibular Stimulation to Trigger Adipose Loss (VeSTAL) Clinical Trial

Role: lead

NCT06051864Not ApplicableCompleted

Electrical Vestibular Nerve Stimulation (VeNS) As a Treatment for Depression

Role: lead

NCT04595968Not ApplicableCompleted

Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus

Role: lead

NCT06470035Not ApplicableNot Yet Recruiting

Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Major Depressive Disorder (MDD)

Role: lead

NCT04433273Not ApplicableNot Yet Recruiting

Electrical Vestibular Stimulation (VeNS): Assessment of AMPK & SIRT1 Following Repeated Usage

Role: lead

NCT05845658Not ApplicableCompleted

Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety: A Randomized Clinical Trial

Role: lead

NCT04783883Completed

Electrical Vestibular Nerve Stimulation (VeNS): A Follow-up Assessment of Long-term Usage

Role: lead

NCT04999709Not ApplicableCompleted

Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety

Role: lead

NCT04780893Not ApplicableWithdrawn

Electrical Vestibular Nerve Stimulation (VeNS) as a Method of Sleep Management in People With PTSD

Role: lead

NCT04149951Not ApplicableCompleted

Effect of VeSTAL Device in Type 2 Diabetes Mellitus

Role: lead

NCT04452981Not ApplicableCompleted

Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Insomnia

Role: lead

NCT05907967Not ApplicableCompleted

Electrical Vestibular Stimulation (VeNS), Compared to a Sham Control For The Management Of Anxiety

Role: lead

NCT05275790Not ApplicableCompleted

Efficacy of Electrical Vestibular Nerve Stimulation (VeNS) in the Management of Obesity: A Randomized Clinical Trial

Role: lead

NCT04450550Not ApplicableCompleted

Electrical Vestibular Nerve Stimulation (VeNS) in the Management of Parkinson's Disease

Role: lead

NCT04110717Not ApplicableCompleted

Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control as a Means of Reducing Excess Body Weight

Role: lead

NCT04219566Not ApplicableCompleted

Vestibular Nerve Stimulation to Improve Sleep

Role: lead

NCT03138369Terminated

Vestibular Stimulation to Trigger Adipose Loss Clinical Trial

Role: lead

All 20 trials loaded